Akorn Rifampin Capsules 300mg Recall: Stability Issues After Company Closure

Take action

Contact the company & request your remedy

Recalling firmAkorn, Inc.5605 Centerpoint Ct Ste A, N/A · Gurnee, IL 60031-5278

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Akorn is recalling 300mg Rifampin Capsules in 30-count and 60-count bottles because the company went out of business and could no longer perform stability tests. This means the medication may not be safe for long-term use.

Why it’s dangerous

The recall occurs because Akorn went out of business and stopped stability testing. Without this testing, the medication's effectiveness and safety over time cannot be confirmed, which could lead to treatment failure or adverse effects.

Who’s affected

Prescription patients who have received Rifampin Capsules from Akorn. Those with ongoing treatment needs are most at risk due to potential medication instability.

How to tell if you have this one

Check for Akorn-branded Rifampin Capsules USP 300mg in 30-count or 60-count bottles. All lots and all NDC numbers are affected.

Brand
Akorn
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Identify if you have Akorn Rifampin Capsules USP 300mg in 30-count or 60-count bottles.

✎ GovInfoNow

Questions people ask

Why is this medication being recalled?

The company went out of business and could no longer continue stability studies, which are necessary to ensure the medication remains safe and effective over time.

Do I need to stop using this medication?

The recall does not specify a remedy, so you should not assume you need to stop using it immediately. However, consult your healthcare provider for guidance.

Is there a fix or replacement available?

The official notice does not mention any remedy or replacement options.

Take action

Contact Akorn

We’ve drafted a message you can send Akorn to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0841-2023 — Akorn Akorn

Hello,

I own a Akorn that is covered by recall D-0841-2023 from Akorn.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0841-2023 (April 26, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0841-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Akorn, Inc. recalls Rifampin Capsules USP, 300 mg, packaged in a) 30 count bottles and b) 60 count bottles, Rx Only, Distributed by: Akorn

Recall notice